Latest News and Press Releases

Cohen Milstein seeks Zenas BioPharma (ZBIO) investors to join and/or lead class action to hold Zenas BioPharma accountable for IPO-related fraud.

Cohen Milstein Encourages Zenas BioPharma Investors Who Lost Money Following IPO Stock Collapse to Call Firm to Potentially Join or Lead Class Action.

Investors who purchased stock in Zenas BioPharma, Inc. (NASDAQ: ZBIO) September 2024 IPO and lost money should call Cohen Milstein to join a class action.

WASHINGTON, April 24, 2025 (GLOBE NEWSWIRE) -- Investors in Zenas BioPharma, Inc. (NASDAQ: ZBIO) who bought shares in the company’s September 2024 IPO may be eligible to participate in and lead a...

Cohen Milstein Calls on Zenas BioPharma (ZBIO) Investors to Act Following Significant Post-IPO Losses

Zenas Biopharma Investors Urged to Contact Cohen Milstein After Post-IPO Losses

Investors who lost money on securities of Zenas BioPharma, Inc. (NASDAQ: ZBIO) encouraged to call Cohen Milstein.

WASHINGTON, July 06, 2016 (GLOBE NEWSWIRE) -- The law firms of Cohen Milstein Sellers & Toll PLLC and Susman Godfrey L.L.P., along with the NAACP and other attorneys, have filed a state class...

WASHINGTON, June 30, 2016 (GLOBE NEWSWIRE) -- Cohen Milstein Sellers & Toll PLLC is conducting an investigation to determine whether Unilife Corporation (“Unilife” or the “Company”) and certain...

WASHINGTON, June 16, 2016 (GLOBE NEWSWIRE) -- Jonathan B. Baker, Professor of Law at American University Washington College of Law, has been selected as the recipient of the 14th Annual Jerry S....